Skip to main content
Top
Published in: HSS Journal ® 2/2006

01-09-2006

Perioperative Management of Medications Used in the Treatment of Rheumatoid Arthritis

Authors: Carla R. Scanzello, MD, PhD, Mark P. Figgie, MD, Bryan J. Nestor, MD, Susan M. Goodman, MD

Published in: HSS Journal ® | Issue 2/2006

Login to get access

Abstract

Patients with rheumatoid arthritis (RA), an inflammatory arthritis that can destroy joint structures, are often on multiple medications to control disease activity. These medications may have significant toxicities and side effects. Over the course of their lifetime, patients with this disease often require orthopedic procedures, including total joint arthroplasty, and the medications they are taking present management issues specific to the perioperative period. As many of these medications are immunosuppressive, the concern for postoperative infection and delayed wound healing are particularly worrisome. We conducted a review of the available literature pertaining to the perioperative use of the most commonly prescribed medications for RA. Although the existing data directly addressing perioperative complications in orthopedic surgery is sparse, information on relevant complications resulting from the general use of these drugs may be used as a basis for conservative recommendations.
Literature
1.
go back to reference An YH, Friedman RJ (1996) Prevention of sepsis in total joint arthroplasty. J Hosp Infect 33:93–108PubMedCrossRef An YH, Friedman RJ (1996) Prevention of sepsis in total joint arthroplasty. J Hosp Infect 33:93–108PubMedCrossRef
2.
go back to reference Schlaghecke R, Kornely E, Santen RT, Ridderskamp P (1992) The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med 326:226–230PubMedCrossRef Schlaghecke R, Kornely E, Santen RT, Ridderskamp P (1992) The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med 326:226–230PubMedCrossRef
3.
go back to reference McPhee IB, Williams RP, Swanson CE (1998) Factors influencing wound healing after surgery for metastatic disease of the spine. Spine 23:726–732PubMedCrossRef McPhee IB, Williams RP, Swanson CE (1998) Factors influencing wound healing after surgery for metastatic disease of the spine. Spine 23:726–732PubMedCrossRef
4.
go back to reference Busti AJ, Hooper JS, Amaya CJ, Kazi S (2005) Effects of perioperative anti-inflammatory and immunomodulating therapy on surgical wound healing. Pharmacotherapy 25:1566–1591PubMedCrossRef Busti AJ, Hooper JS, Amaya CJ, Kazi S (2005) Effects of perioperative anti-inflammatory and immunomodulating therapy on surgical wound healing. Pharmacotherapy 25:1566–1591PubMedCrossRef
5.
go back to reference Mathis AS, Shah NK, Mulgaonkar S (2004) Stress dose steroids in renal transplant patients undergoing lymphocele surgery. Transplant Proc 36:3042–3045PubMedCrossRef Mathis AS, Shah NK, Mulgaonkar S (2004) Stress dose steroids in renal transplant patients undergoing lymphocele surgery. Transplant Proc 36:3042–3045PubMedCrossRef
6.
go back to reference Bromberg JS, Alfrey EJ, Barker CF, et al (1991) Adrenal suppression and steroid supplementation in renal transplant recipients. Transplantation 51:385–390PubMedCrossRef Bromberg JS, Alfrey EJ, Barker CF, et al (1991) Adrenal suppression and steroid supplementation in renal transplant recipients. Transplantation 51:385–390PubMedCrossRef
7.
go back to reference Glowniak JV, Loriaux DL (1997) A double-blind study of perioperative steroid requirements in secondary adrenal insufficiency. Surgery 121:123–129PubMedCrossRef Glowniak JV, Loriaux DL (1997) A double-blind study of perioperative steroid requirements in secondary adrenal insufficiency. Surgery 121:123–129PubMedCrossRef
8.
go back to reference Leopold SS, Casnellie MT, Warme WJ, et al (2003) Endogenous cortisol production in response to knee arthroscopy and total knee arthroplasty. J Bone Jt Surg Am Vol 85-A:2163–2167 Leopold SS, Casnellie MT, Warme WJ, et al (2003) Endogenous cortisol production in response to knee arthroscopy and total knee arthroplasty. J Bone Jt Surg Am Vol 85-A:2163–2167
9.
go back to reference Bruewer M, Utech M, Rijcken EJ, et al (2003) Preoperative steroid administration: effect on morbidity among patients undergoing intestinal bowel resection for Crohns disease. World J Surg 27:1306–1310PubMedCrossRef Bruewer M, Utech M, Rijcken EJ, et al (2003) Preoperative steroid administration: effect on morbidity among patients undergoing intestinal bowel resection for Crohns disease. World J Surg 27:1306–1310PubMedCrossRef
10.
go back to reference Aberra FN, Lewis JD, Hass D, et al (2003) Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology 125:320–327PubMedCrossRef Aberra FN, Lewis JD, Hass D, et al (2003) Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology 125:320–327PubMedCrossRef
11.
go back to reference Jain A, Witbreuk M, Ball C, Nanchahal J (2002) Influence of steroids and methotrexate on wound complications after elective rheumatoid hand and wrist surgery. J Hand Surg [Am] 27:449–455CrossRef Jain A, Witbreuk M, Ball C, Nanchahal J (2002) Influence of steroids and methotrexate on wound complications after elective rheumatoid hand and wrist surgery. J Hand Surg [Am] 27:449–455CrossRef
12.
go back to reference Hanssen AD, Cabanela ME, Michet CJ Jr (1987) Hip arthroplasty in patients with systemic lupus erythematosus. J Bone Jt Surg Am Vol 69:807–814 Hanssen AD, Cabanela ME, Michet CJ Jr (1987) Hip arthroplasty in patients with systemic lupus erythematosus. J Bone Jt Surg Am Vol 69:807–814
13.
go back to reference Levitsky J, Te HS, Cohen SM (2003) The safety and outcome of joint replacement surgery in liver transplant recipients. Liver Transplant 9:373–376CrossRef Levitsky J, Te HS, Cohen SM (2003) The safety and outcome of joint replacement surgery in liver transplant recipients. Liver Transplant 9:373–376CrossRef
14.
go back to reference Cronstein BN (2005) Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev 57:163–172PubMedCrossRef Cronstein BN (2005) Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev 57:163–172PubMedCrossRef
15.
go back to reference Choi HK, Hernan MA, Seeger JD, et al (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359:1173–1177PubMedCrossRef Choi HK, Hernan MA, Seeger JD, et al (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359:1173–1177PubMedCrossRef
16.
go back to reference Pincus T, Yazici Y, Sokka T, et al (2003) Methotrexate as the “anchor drug” for the treatment of early rheumatoid arthritis. Clin Exp Rheumatol 21:S179–S185PubMed Pincus T, Yazici Y, Sokka T, et al (2003) Methotrexate as the “anchor drug” for the treatment of early rheumatoid arthritis. Clin Exp Rheumatol 21:S179–S185PubMed
17.
go back to reference Grennan DM, Gray J, Loudon J, Fear S (2001) Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 60:214–217PubMedCrossRef Grennan DM, Gray J, Loudon J, Fear S (2001) Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 60:214–217PubMedCrossRef
18.
go back to reference Sany J, Anaya JM, Canovas F et al (1993) Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis. J Rheumatol 20:1129–1132PubMed Sany J, Anaya JM, Canovas F et al (1993) Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis. J Rheumatol 20:1129–1132PubMed
19.
go back to reference Carpenter MT, West SG, Vogelgesang SA, Casey Jones DE (1996) Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy. Orthopedics 19:207–210PubMed Carpenter MT, West SG, Vogelgesang SA, Casey Jones DE (1996) Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy. Orthopedics 19:207–210PubMed
20.
go back to reference Bibbo C, Anderson RB, Davis WH, Norton J (2003) The influence of rheumatoid chemotherapy, age, and presence of rheumatoid nodules on postoperative complications in rheumatoid foot and ankle surgery: analysis of 725 procedures in 104 patients. Foot Ankle Int 24:40–44PubMed Bibbo C, Anderson RB, Davis WH, Norton J (2003) The influence of rheumatoid chemotherapy, age, and presence of rheumatoid nodules on postoperative complications in rheumatoid foot and ankle surgery: analysis of 725 procedures in 104 patients. Foot Ankle Int 24:40–44PubMed
21.
go back to reference Bland KI, Palin WE, von Fraunhofer JA et al (1984) Experimental and clinical observations of the effects of cytotoxic chemotherapeutic drugs on wound healing. Ann Surg 199:782–790PubMedCrossRef Bland KI, Palin WE, von Fraunhofer JA et al (1984) Experimental and clinical observations of the effects of cytotoxic chemotherapeutic drugs on wound healing. Ann Surg 199:782–790PubMedCrossRef
22.
go back to reference Cohen SC, Gabelnick HL, Johnson RK, Goldin A (1975) Effects of antineoplastic agents on wound healing in mice. Surgery 78:238–244PubMed Cohen SC, Gabelnick HL, Johnson RK, Goldin A (1975) Effects of antineoplastic agents on wound healing in mice. Surgery 78:238–244PubMed
23.
go back to reference Hernigou P, Thiery JP, Benoit J et al (1989) Methotrexate diffusion from acrylic cement. Local chemotherapy for bone tumours. J Bone Jt Surg Br 71:804–811 Hernigou P, Thiery JP, Benoit J et al (1989) Methotrexate diffusion from acrylic cement. Local chemotherapy for bone tumours. J Bone Jt Surg Br 71:804–811
24.
go back to reference Shamberger RC, Devereux DF, Brennan MF (1981) The effect of chemotherapeutic agents on wound healing. Int Adv Surg Oncol 4:15–58PubMed Shamberger RC, Devereux DF, Brennan MF (1981) The effect of chemotherapeutic agents on wound healing. Int Adv Surg Oncol 4:15–58PubMed
25.
go back to reference Kasdan ML, June L (1993) Postoperative results of rheumatoid arthritis patients on methotrexate at the time of reconstructive surgery of the hand. Orthopedics 16:1233–1235PubMed Kasdan ML, June L (1993) Postoperative results of rheumatoid arthritis patients on methotrexate at the time of reconstructive surgery of the hand. Orthopedics 16:1233–1235PubMed
26.
go back to reference Lim V, Pande I (2002) Leflunomide can potentiate the anticoagulant effect of warfarin. BMJ 325:1333PubMedCrossRef Lim V, Pande I (2002) Leflunomide can potentiate the anticoagulant effect of warfarin. BMJ 325:1333PubMedCrossRef
27.
go back to reference Feldmann MM, Maini RN (2002) Discovery of TNF-α as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies. Joint, Bone, Spine 69:12–18PubMedCrossRef Feldmann MM, Maini RN (2002) Discovery of TNF-α as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies. Joint, Bone, Spine 69:12–18PubMedCrossRef
28.
go back to reference Hochberg MC, Tracy JK, Hawkins-Holt M, Flores RH (2003) Comparison of the efficacy of the tumour necrosis factor α blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis. Ann Rheum Dis 62(Suppl 2):ii13–ii16PubMed Hochberg MC, Tracy JK, Hawkins-Holt M, Flores RH (2003) Comparison of the efficacy of the tumour necrosis factor α blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis. Ann Rheum Dis 62(Suppl 2):ii13–ii16PubMed
29.
go back to reference Lipsky PE, van der Heijde DM, St Clair EW et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. NEJM 343:1594–1602PubMedCrossRef Lipsky PE, van der Heijde DM, St Clair EW et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. NEJM 343:1594–1602PubMedCrossRef
30.
go back to reference Hyrich KL, Silman AJ, Watson KD, Symmons DP (2004) Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety. Ann Rheum Dis 63:1538–1543PubMedCrossRef Hyrich KL, Silman AJ, Watson KD, Symmons DP (2004) Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety. Ann Rheum Dis 63:1538–1543PubMedCrossRef
31.
go back to reference Fisher CJ, Agosti JM, Opal SM et al (1996) Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. NEJM 334:1697–1702PubMedCrossRef Fisher CJ, Agosti JM, Opal SM et al (1996) Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. NEJM 334:1697–1702PubMedCrossRef
32.
go back to reference Marchal L, D'Haens G, Van Assche G et al (2004) The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study. Aliment Pharmacol Ther 19:749–754PubMedCrossRef Marchal L, D'Haens G, Van Assche G et al (2004) The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study. Aliment Pharmacol Ther 19:749–754PubMedCrossRef
33.
go back to reference Colombel JF, Loftus EV Jr, Tremaine WJ et al (2004) Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 99:878–883PubMedCrossRef Colombel JF, Loftus EV Jr, Tremaine WJ et al (2004) Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 99:878–883PubMedCrossRef
34.
go back to reference Bibbo C, Goldberg JW (2004) Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy. Foot Ankle Int 25:331–335PubMed Bibbo C, Goldberg JW (2004) Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy. Foot Ankle Int 25:331–335PubMed
35.
go back to reference Giles JT, Bartlett SJ, Gelber AC, et al (2006) Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in Rheumatoid Arthritis. Arthritis Care Res 55:333–337CrossRef Giles JT, Bartlett SJ, Gelber AC, et al (2006) Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in Rheumatoid Arthritis. Arthritis Care Res 55:333–337CrossRef
36.
go back to reference Kawaguchi HH, Hizuta AA, Tanaka NN, Orita KK (1995) Role of endotoxin in wound healing impairment. Res Commun Mol Pathol Pharmacol 89:317–327PubMed Kawaguchi HH, Hizuta AA, Tanaka NN, Orita KK (1995) Role of endotoxin in wound healing impairment. Res Commun Mol Pathol Pharmacol 89:317–327PubMed
37.
go back to reference Doran MF, Crowson CS, Pond GR, et al (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 46:2287–2293PubMedCrossRef Doran MF, Crowson CS, Pond GR, et al (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 46:2287–2293PubMedCrossRef
38.
go back to reference Edwards JC, Szczepanski L, Szechinski J, et al (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. NEJM 350:2572–2581PubMedCrossRef Edwards JC, Szczepanski L, Szechinski J, et al (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. NEJM 350:2572–2581PubMedCrossRef
39.
go back to reference White CA, Weaver RL, Grillo-Lopez AJ (2001) Antibody-targeted immunotherapy for treatment of malignancy. Annu Rev Med 52:125–145PubMedCrossRef White CA, Weaver RL, Grillo-Lopez AJ (2001) Antibody-targeted immunotherapy for treatment of malignancy. Annu Rev Med 52:125–145PubMedCrossRef
40.
go back to reference Sarrecchia C, Cappelli A, Aiello P (2005) HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb. J Infect Chemother 11:189–191PubMedCrossRef Sarrecchia C, Cappelli A, Aiello P (2005) HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb. J Infect Chemother 11:189–191PubMedCrossRef
41.
go back to reference Law JK, Ho JK, Hoskins PJ, et al (2005) Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations. Leuk Lymphoma 46:1085–1089PubMedCrossRef Law JK, Ho JK, Hoskins PJ, et al (2005) Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations. Leuk Lymphoma 46:1085–1089PubMedCrossRef
42.
go back to reference Tsutsumi Y, Kanamori H, Mori A, et al (2005) Reactivation of hepatitis B virus with rituximab. Expert Opin Drug Safety 4:599–608CrossRef Tsutsumi Y, Kanamori H, Mori A, et al (2005) Reactivation of hepatitis B virus with rituximab. Expert Opin Drug Safety 4:599–608CrossRef
43.
go back to reference Cambridge G, Leandro MJ, Edwards JC, et al (2003) Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum 48:2146–2154PubMedCrossRef Cambridge G, Leandro MJ, Edwards JC, et al (2003) Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum 48:2146–2154PubMedCrossRef
Metadata
Title
Perioperative Management of Medications Used in the Treatment of Rheumatoid Arthritis
Authors
Carla R. Scanzello, MD, PhD
Mark P. Figgie, MD
Bryan J. Nestor, MD
Susan M. Goodman, MD
Publication date
01-09-2006
Publisher
Springer-Verlag
Published in
HSS Journal ® / Issue 2/2006
Print ISSN: 1556-3316
Electronic ISSN: 1556-3324
DOI
https://doi.org/10.1007/s11420-006-9012-5

Other articles of this Issue 2/2006

HSS Journal ® 2/2006 Go to the issue